INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.
International access laws and requirements in BS. Citations, verification dates, and source links for every data point.
| Dimension | Value | Citation | Source | Verified | Confidence |
|---|---|---|---|---|---|
| Offer International Treatment Availability | Stem cell, gene, immunotherapy, regenerative and longevity therapies approved under the Longevity and Regenerative Therapies Act 2024 (in force 1 Sep 2024; replaced Stem Cell Research and Therapy Act 2013); providers must be licensed health care facilities | Longevity and Regenerative Therapies Act, 2024 ss. 2, 3, 20, 26; Appointed Day Notice S.I. 73 of 2024“The purpose of this Act is — (a) to create in the Commonwealth of The Bahamas a legal framework for research and approval of therapies, as defined in this Act ... 26. Repeal. The Stem Cell Research and Therapy Act (Ch. 235B) is repealed.”Note: Act defines 'regenerative therapy' (cell therapy, immunotherapy, tissue engineering, stem cell products) and 'gene therapy'. s.20(1): 'Any healthcare facility used for the purpose of providing therapy or conducting research shall be licensed as a healthcare facility in accordance with the provisions of the Hospitals and Health Care Facilities Act'. Appointed day 1 Sept 2024 per S.I. 73/2024 (https://laws.bahamas.gov.bs/cms/images/LEGISLATION/SUBORDINATE/2024/2024-0073/2024-0073_1.pdf). PDF text layer is garbled (overlaid with another Act); quotes read from rendered page images. 'Exosome treatments', 'wellness' and 'limited oversight' not stated; dropped. | Link | 2026-10-09 | high |
| Recognize International Practitioner Licensure | Bahamas Medical Council registration required to practise; temporary registration up to six months for qualified practitioners residing temporarily in The Bahamas | Medical Act (Ch. 224) ss. 15, 22“15. (1) No person shall practice medicine or surgery unless he is registered by the Council under this Act. ... 22. (1) The Council or the Registrar may register, temporarily, for a period not exceeding six months”Note: s.22(1)(b): applicant must satisfy the Council 'that he is residing temporarily in The Bahamas and would otherwise qualify for registration'. 'Relatively streamlined for medical tourism practitioners' is a marketing characterisation; dropped. | Link | 2026-10-09 | high |
| Have Pharmaceutical Import Rules | Drug imports require Bahamas Pharmacy Council approval of manufacturer and product documentation, shown to customs on import | Pharmacy (Import and Export) Regulations reg. 3; Pharmacy Act (Ch. 227) s. 28“Any person who desires to import or export any drugs for the purposes of the Act shall submit to the Council for approval the following supporting documentation ... Evidence of approval granted under paragraph (1) shall be produced to the customs officer upon import or export”Note: Regulator is the Bahamas Pharmacy Council (Pharmacy Act Part II), not a 'Pharmacy Board'. 'Medical tourism operators often manage logistics' unsupported; dropped. Under the 2024 LRT Act the Board also regulates storage and shipping of therapies into The Bahamas (s.25 regulation-making power). | Link | 2026-10-09 | high |
| Have International Malpractice Regimes | Not verified | Not verified: no adequate source found in the October 2026 reviewNote: No source read states 'limited precedent for medical tourism liability' or that 'arbitration clauses are common'. Bahamian common-law basis not confirmed from a primary source in this pass. Medical Act (Ch. 224) covers registration and discipline, not civil liability. Web search budget was exhausted mid-batch, limiting further searching. | Link | 2026-10-09 | derived |
View full BS profile (all layers) · Report an error on this page